163 related articles for article (PubMed ID: 21724278)
21. The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
Heinzmann D; Bangert A; Müller AM; von Ungern-Sternberg SN; Emschermann F; Schönberger T; Chatterjee M; Mack AF; Klingel K; Kandolf R; Malesevic M; Borst O; Gawaz M; Langer HF; Katus H; Fischer G; May AE; Kaya Z; Seizer P
PLoS One; 2015; 10(4):e0124606. PubMed ID: 25894208
[TBL] [Abstract][Full Text] [Related]
22.
Li L; Luo D; Liao Y; Peng K; Zeng Y
Front Immunol; 2020; 11():2052. PubMed ID: 33013867
[No Abstract] [Full Text] [Related]
23. Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm.
Piechota-Polanczyk A; Demyanets S; Nykonenko O; Huk I; Mittlboeck M; Domenig CM; Neumayer C; Wojta J; Nanobachvili J; Klinger M
Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):682-8. PubMed ID: 23558220
[TBL] [Abstract][Full Text] [Related]
24. CXCL16 is a novel diagnostic marker and predictor of mortality in inflammatory cardiomyopathy and heart failure.
Borst O; Schaub M; Walker B; Sauter M; Muenzer P; Gramlich M; Mueller K; Geisler T; Lang F; Klingel K; Kandolf R; Bigalke B; Gawaz M; Zuern CS
Int J Cardiol; 2014 Oct; 176(3):896-903. PubMed ID: 25223819
[TBL] [Abstract][Full Text] [Related]
25. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
[TBL] [Abstract][Full Text] [Related]
26. Extracellular cyclophilin A induces cardiac hypertrophy via the ERK/p47phox pathway.
Cao M; Mao Z; Peng M; Zhao Q; Sun X; Yan J; Yuan W
Mol Cell Endocrinol; 2020 Dec; 518():110990. PubMed ID: 32805334
[TBL] [Abstract][Full Text] [Related]
27. CD147 stimulates hepatoma cells escaping from immune surveillance of T cells by interaction with Cyclophilin A.
Ren YX; Wang SJ; Fan JH; Sun SJ; Li X; Padhiar AA; Zhang JN
Biomed Pharmacother; 2016 May; 80():289-297. PubMed ID: 27133068
[TBL] [Abstract][Full Text] [Related]
28. Cyclophilin A (CyPA) induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147.
Song F; Zhang X; Ren XB; Zhu P; Xu J; Wang L; Li YF; Zhong N; Ru Q; Zhang DW; Jiang JL; Xia B; Chen ZN
J Biol Chem; 2011 Mar; 286(10):8197-8203. PubMed ID: 21245143
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and MMP10, MMP23 in inflammatory bowel disease: Cross-sectional study.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Martínez-Benitez B; Barreto-Zuñiga R; Yamamoto-Furusho JK
Scand J Immunol; 2021 Jan; 93(1):e12962. PubMed ID: 32853407
[TBL] [Abstract][Full Text] [Related]
30. Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy.
Han JM; Jung HJ
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012604
[TBL] [Abstract][Full Text] [Related]
31. Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.
Yurchenko V; Constant S; Eisenmesser E; Bukrinsky M
Clin Exp Immunol; 2010 Jun; 160(3):305-17. PubMed ID: 20345978
[TBL] [Abstract][Full Text] [Related]
32. Role of CD147 (EMMPRIN/Basigin) in Tissue Remodeling.
Guindolet D; Gabison EE
Anat Rec (Hoboken); 2020 Jun; 303(6):1584-1589. PubMed ID: 30768865
[TBL] [Abstract][Full Text] [Related]
33. Extracellular cyclophilin A may be a potential target to protect against myocardial reperfusion injury.
Wang WL; Yuan YJ; Xue FS; Liao X; Wang Q; Xiong J; Liu JH
Med Hypotheses; 2011 Nov; 77(5):734-8. PubMed ID: 21824732
[TBL] [Abstract][Full Text] [Related]
34. Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.
Bi XC; Liu JM; He HC; Ye YK; Han ZD; Dai QS; Liang YX; Cai C; Chen JH; Chen XB; Qin GQ; Zeng GH; Zhong WD
Clin Transl Oncol; 2012 Mar; 14(3):190-6. PubMed ID: 22374422
[TBL] [Abstract][Full Text] [Related]
35. Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.
von Ungern-Sternberg SNI; Zernecke A; Seizer P
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419744
[TBL] [Abstract][Full Text] [Related]
36. Extracellular and Intracellular Cyclophilin A, Native and Post-Translationally Modified, Show Diverse and Specific Pathological Roles in Diseases.
Xue C; Sowden MP; Berk BC
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):986-993. PubMed ID: 29599134
[TBL] [Abstract][Full Text] [Related]
37. Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
Hahn JN; Kaushik DK; Mishra MK; Wang J; Silva C; Yong VW
J Immunol; 2016 Nov; 197(10):3850-3860. PubMed ID: 27733550
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Cyclophilin A in Human Periapical Lesions.
Wang Y; Liu G; Zhang J; Zhu L; Yu J; Zhu S; Lv F; Peng B
J Endod; 2019 Dec; 45(12):1496-1503. PubMed ID: 31623908
[TBL] [Abstract][Full Text] [Related]
39. Extracellular Cyclophilin A Augments Platelet-Dependent Thrombosis and Thromboinflammation.
von Ungern-Sternberg SNI; Vogel S; Walker-Allgaier B; Geue S; Maurer A; Wild AM; Münzer P; Chatterjee M; Heinzmann D; Kremmer E; Borst O; Loughran P; Zernecke A; Neal MD; Billiar TR; Gawaz M; Seizer P
Thromb Haemost; 2017 Nov; 117(11):2063-2078. PubMed ID: 28981554
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin attenuated rat thoracic aorta remodeling by decreasing ROCK2‑mediated CyPA secretion and CD147‑ERK1/2‑cyclin pathway.
Tang FC; Wang HY; Ma MM; Guan TW; Pan L; Yao DC; Chen YL; Li SJ; Yang H; Zhu XQ; Tu YS
Mol Med Rep; 2017 Dec; 16(6):8123-8129. PubMed ID: 28983618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
